en

PRODUCT DETAIL

Neofordex 40 mg tablety

Code 8954B
MA number EU/1/15/1053/001
Product Form: tbl 10x1x40 mg (blis.OPA/Al/PVC-Al-perf.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: THERAVIA, France
Therapeutic Class: 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU)
ATC:
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02AB Glucocorticoids
H02AB02 Dexamethasone
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 16.03.2016
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 15.01.2021
eu-flag.png sk-flag.png